Measuring oxygen levels in muscle for mitochondrial myopathy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to validate an electrochemical oxygen nanosensor for assessing mitochondrial function in patients with mitochondrial myopathy (MM) and healthy volunteers. Participants will undergo muscle oxygen measurements during handgrip exercise, with follow-up assessments to evaluate the reproducibility of the results. The study seeks to establish reliable biomarkers that reflect disease severity and therapeutic response, which could enhance future treatment strategies for mitochondrial diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria for Healthy Controls

1. Males and females, between the ages of 18 and 65 years, inclusive
2. Provide informed consent for study participation; able to understand and complete the protocol
3. Able to ambulate independently
4. Able to perform bicycle ergometry

Inclusion Criteria for MM Cases

1. Males and females, between the ages of 18 and 65 years, inclusive
2. Provide informed consent for study participation; able to understand and complete the protocol
3. Genetically-confirmed MM as defined by a diagnosis of primary mitochondrial disease (PMD) with predominant symptoms of myopathy as expressed by exercise intolerance and muscle weakness and fatigue.
4. Previously enrolled (or will enroll) in Children's Hospital of Philadelphia (CHOP) Institutional Review Board (IRB) study #08-006177 (Falk, PI) or CHOP IRB #16-013364 (Zolkipli, PI)
5. Able to ambulate independently
6. Able to perform bicycle ergometry

Exclusion Criteria for All Participants

Subjects will be excluded if any of the following apply:

1. Unable to provide informed consent and complete all study procedures, including ergometry
2. Non-ambulatory or unable to ambulate independently
3. Pregnant
4. Within 1 month of a recent hospital admission due to acute illness
5. Have severe cardiac disease as defined by an ejection fraction of less than 35% and New York Heart Association Functional Classification Class III; or severe pulmonary disease as defined by the need for supplemental O2 therapy or daytime ventilatory support
6. Have a tracheostomy
7. Have a known bleeding disorder and/or family history (first-degree relative) with a known bleeding disorder
8. Daily intake of aspirin or any other anti-platelet therapy which cannot be temporarily discontinued for medical reasons
9. a) Have known or suspected congenital or acquired immune deficiency; b) concurrent use of immunosuppressive drugs, including corticosteroids; c) past history of recurrent (more than 6 times per year) severe (required hospitalization) skin or soft tissue infections; d) history of infection or delayed wound healing after surgery or biopsy; e) known history of neutropenia with absolute neutrophil count less than 500/mm3
10. Undergo chronic steroid treatment as defined by daily oral intake (for more than 1 month) or have existing untreated endocrinopathies, such as hypothyroidism that caused acquired myopathy
11. Prone to hypertrophic scars and keloids
12. Have any other known inherited myopathy, such as Duchenne muscular dystrophy or congenital myopathy
13. Known allergy to lidocaine
14. Have a cognitive impairment that may prevent the ability to complete study procedures
15. Unable to comply with the requirements of the study protocol and/or unsuitable for the study for any reason, in the opinion of the principal investigator
16. Individuals from vulnerable populations (e.g., prisoners/detainees)
17. Participants who are unable to speak and/or read English (as participants will be required to be proficient to complete study procedures)

Where it's running

• The Children's Hospital of Philadelphia
  Philadelphia, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Zarazuela Zolkipli-Cunningham — Children's Hospital of Philadelphia
• Study coordinator: Zarazuela Zolkipli-Cunningham
• Email: zolkipliz@chop.edu
• Phone: (267) 426 4961

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of passive exercise on mitochondrial diseases

  This study is testing how different types of exercise, including passive exercise, affect people with mitochondrial diseases compared to healthy individuals.

  Recruiting Phase 1 Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT05569122

• Global registry for mitochondrial disorders

  This study is creating a global database for mitochondrial disorders to help understand these diseases better and improve future treatments for patients.

  Recruiting at 34 sites LMU Klinikum · Innsbruck and 33 other locations · NCT05554835

• Metabolic and Functional Study of γδ T Cells in Critically Ill Patients

  Researchers will look at how γδ T cells behave in severely ill patients, including those with sepsis, to see how their metabolism and function change.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Outside of the US · NCT07680816

• Open-label extension to test KL1333 long-term safety and benefit for primary mitochondrial disease

  This extension study will see if KL1333 can be safely used long-term and whether it helps reduce fatigue and improve daily living in adults with primary mitochondrial disease who previously took KL1333 or placebo.

  Recruiting at 23 sites Phase 2 Pharming Technologies B.V. · Akron, Ohio and 22 other locations · NCT07514338

• One-leg exercise training to improve muscle energy and function in adults with mitochondrial myopathy

  This project tests whether a short program of one-leg high-intensity interval exercise changes muscle energy production and molecular signals in adults with mitochondrial myopathy compared with healthy adults.

  Recruiting University of Copenhagen · Copenhagen · NCT07450690

• Measuring oxygen levels in muscle tissue using a nanosensor

  This study is testing a tiny sensor to see if it can accurately measure oxygen levels in the muscles of people with mitochondrial myopathy and healthy volunteers during exercise.

  Recruiting Phase 1 Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT06819683

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.